[HTML][HTML] Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2025 update

N Kawel-Boehm, SJ Hetzel… - Journal of …, 2025 - Elsevier
Quantitative assessment of morphological and functional cardiac parameters by
cardiovascular magnetic resonance (CMR) is essential for research and routine clinical …

Transthyretin cardiac amyloidosis

A Porcari, M Fontana, JD Gillmore - Cardiovascular Research, 2022 - academic.oup.com
Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart
failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the …

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

P Garcia-Pavia, C Rapezzi, Y Adler, M Arad… - European heart …, 2021 - academic.oup.com
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D …

P Garcia‐Pavia, C Rapezzi, Y Adler… - European journal of …, 2021 - Wiley Online Library
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base …

S Dorbala, Y Ando, S Bokhari… - Circulation …, 2021 - ahajournals.org
Sharmila Dorbala, MD, MPH, FASNC, Chair*; Yukio Ando, MD, PhD†; Sabahat Bokhari,
MD‡; Angela Dispenzieri, MD § ; Rodney H. Falk, MD*; Victor A. Ferrari, MD∥; Marianna …

Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology

PM Seferović, M Polovina, J Bauersachs… - European journal of …, 2019 - Wiley Online Library
Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important
cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural …

[HTML][HTML] Clinical recommendations for cardiovascular magnetic resonance map** of T1, T2, T2* and extracellular volume: a consensus statement by the Society for …

DR Messroghli, JC Moon, VM Ferreira… - Journal of …, 2016 - Elsevier
Parametric map** techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …

How to image cardiac amyloidosis: a practical approach

S Dorbala, S Cuddy, RH Falk - Cardiovascular Imaging, 2020 - jacc.org
Cardiac amyloidosis (CA) is one of the most rapidly progressive forms of heart disease, with
a median survival from diagnosis, if untreated, ranging from< 6 months for light chain …

AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy

RH Falk, KM Alexander, R Liao, S Dorbala - Journal of the American …, 2016 - jacc.org
The amyloidoses are a group of protein-folding disorders in which≥ 1 organ is infiltrated by
proteinaceous deposits known as amyloid. The deposits are derived from 1 of several …

Magnetic resonance in transthyretin cardiac amyloidosis

A Martinez-Naharro, TA Treibel, A Abdel-Gadir… - Journal of the American …, 2017 - jacc.org
Background: Cardiac transthyretin amyloidosis (ATTR) is an increasingly recognized cause
of heart failure. Cardiac magnetic resonance (CMR), with late gadolinium enhancement …